Vitamin D does not modulate NF-κB activity in Jurkat T cells

Immunology Letters

Volumn 131, Issue 2, 2010, Pages 151-158

  Shifera, Amde Selassie ^a   Leong, Deborah ^a   Hardin, John A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CD69; Jurkat cells; NF B; T cells; Vitamin D

Indexed keywords

CALCITRIOL; CD69 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN; VITAMIN D;

ADOLESCENT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPORTER GENE; T LYMPHOCYTE ACTIVATION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; HUMANS; IMMUNOMODULATION; JURKAT CELLS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VITAMIN D;

EID: 77953697103     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.04.001     Document Type: Article

References (53)

1. Griffin M.D., Xing N., Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 2003, 23:117-145.
2. Bhalla A.K., Amento E.P., Clemens T.L., Holick M.F., Krane S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983, 57:1308-1310.
3. Reinhardt T.A., Horst R.L., Littledike E.T., Beitz D.C. 1,25-Dihydroxyvitamin D3 receptor in bovine thymus gland. Biochem Biophys Res Commun 1982, 106:1012-1018.
4. Bar-Shavit Z., Teitelbaum S.L., Reitsma P., Hall A., Pegg L.E., Trial J., et al. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1983, 80:5907-5911.
5. Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981, 78:4990-4994.
6. van E.E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
7. Carlberg C., Polly P. Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr 1998, 8:19-42.
8. Jones G., Strugnell S.A., Deluca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
9. Huang Y., Wange R.L. T cell receptor signaling: beyond complex complexes. J Biol Chem 2004, 279:28827-28830.
10. Kruppa G., Thoma B., Machleidt T., Wiegmann K., Kronke M. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. J Immunol 1992, 148:3152-3157.
11. Li X., Stark G.R. NFkappaB-dependent signaling pathways. Exp Hematol 2002, 30:285-296.
12. Chung J., Koyama T., Ohsawa M., Shibamiya A., Hoshi A., Hirosawa S. 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB. Lab Invest 2007, 87:540-547.
13. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006, 21:889-897.
14. Xing N., LM M.L., Bachman L.A., McKean D.J., Kumar R., Griffin M.D. Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 2002, 297:645-652.
15. Penna G., Amuchastegui S., Giarratana N., Daniel K.C., Vulcano M., Sozzani S., et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007, 178:145-153.
16. Sun J., Kong J., Duan Y., Szeto F.L., Liao A., Madara J.L., et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006, 291:E315-E322.
17. Berry D.M., Clark C.S., Meckling-Gill K.A. 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells. Exp Cell Res 2002, 272:176-184.
18. Adams L.S., Teegarden D. 1,25-dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappaB. J Nutr 2004, 134:2948-2952.
19. Mathiasen I.S., Hansen C.M., Foghsgaard L., Jaattela M. Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B. Int J Cancer 2001, 93:224-231.
20. Komine M., Watabe Y., Shimaoka S., Sato F., Kake K., Nishina H., et al. The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch Dermatol Res 1999, 291:500-506.
21. van E.E., Verlinden L., Giulietti A., Ramos-Lopez E., Branisteanu D.D., Ferreira G.B., et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 2007, 37:395-405.
22. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002, 195:603-616.
23. Matsumura M., Kakishita H., Suzuki M., Banba N., Hattori Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci 2001, 69:1067-1077.
24. Yamazaki T., Tukiyama T., Tokiwa T. Effect of dexamethasone on binding activity of transcription factors nuclear factor-kappaB and activator protein-1 in SW982 human synovial sarcoma cells. In Vitro Cell Dev Biol Anim 2005, 41:80-82.
25. Lu X., Farmer P., Rubin J., Nanes M.S. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem 2004, 92:833-848.
26. Yu X.P., Bellido T., Manolagas S.C. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1995, 92:10990-10994.
27. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 1993, 13:3301-3310.
28. Ginn-Pease M.E., Whisler R.L. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun 1996, 226:695-702.
29. Ting A.T., Pimentel-Muinos F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15:6189-6196.
30. Harhaj E.W., Good L., Xiao G., Uhlik M., Cvijic M.E., Rivera-Walsh I., et al. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 2000, 19:1448-1456.
31. Shifera A.S., Horwitz M.S. Mutations in the zinc finger domain of IKK gamma block the activation of NF-kappa B and the induction of IL-2 in stimulated T lymphocytes. Mol Immunol 2008, 45:1633-1645.
32. Jin Y.J., Friedman J., Burakoff S.J. Regulation of tyrosine phosphorylation in isolated T cell membrane by inhibition of protein tyrosine phosphatases. J Immunol 1998, 161:1743-1750.
33. Shifera A.S., Hardin J.A. PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins. Arch Biochem Biophys 2009, 490:145-157.
34. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27:693-733.
35. Suzuki Y., Ichiyama T., Ohsaki A., Hasegawa S., Shiraishi M., Furukawa S. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol 2009, 113:134-138.
36. Towers T.L., Freedman L.P. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem 1998, 273:10338-10348.
37. Wagner K.D., Wagner N., Sukhatme V.P., Scholz H. Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells. J Am Soc Nephrol 2001, 12:1188-1196.
38. Cornet A., Baudet C., Neveu I., Baron-Van E.A., Brachet P., Naveilhan P. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res 1998, 53:742-746.
39. Gocek E., Kielbinski M., Marcinkowska E. Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett 2007, 581:1751-1757.
40. Pramanik R., Asplin J.R., Lindeman C., Favus M.J., Bai S., Coe F.L. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol 2004, 232:137-143.
41. Chen K.S., Deluca H.F. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995, 1263:1-9.
42. Barletta F., Dhawan P., Christakos S. Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription. Am J Physiol Endocrinol Metab 2004, 286:E598-E608.
43. Fiedler M.A., Wernke-Dollries K., Stark J.M. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol 1998, 19:259-268.
44. Lopez-Cabrera M., Munoz E., Blazquez M.V., Ursa M.A., Santis A.G., Sanchez-Madrid F. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J Biol Chem 1995, 270:21545-21551.
45. Castellanos M.C., Munoz C., Montoya M.C., Lara-Pezzi E., Lopez-Cabrera M., de Landazuri M.O. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1. J Immunol 1997, 159:5463-5473.
46. Takeuchi A., Reddy G.S., Kobayashi T., Okano T., Park J., Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J Immunol 1998, 160:209-218.
47. Jeffery L.E., Burke F., Mura M., Zheng Y., Qureshi O.S., Hewison M., et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009, 183:5458-5467.
48. Watson K.E., Abrolat M.L., Malone L.L., Hoeg J.M., Doherty T., Detrano R., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
49. Griffin M.D., Dong X., Kumar R. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys 2007, 460:218-226.
50. Dong X., Lutz W., Schroeder T.M., Bachman L.A., Westendorf J.J., Kumar R., et al. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc Natl Acad Sci USA 2005, 102:16007-16012.
51. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 1997, 272:30412-30420.
52. Thomas R.S., Tymms M.J., McKinlay L.H., Shannon M.F., Seth A., Kola I. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 1997, 14:2845-2855.
53. Towers T.L., Staeva T.P., Freedman L.P. A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol Cell Biol 1999, 19:4191-4199.